ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
The Ma’anshan site approval covers pastilles, oral liquids, and powders
The payment is in accordance with the agreed contractual terms
The company has received approval from DCGI to begin patient enrolment and dosing in the country
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Subscribe To Our Newsletter & Stay Updated
